Avalon Investment & Advisory Pacira Bio Sciences, Inc. Transaction History

Avalon Investment & Advisory

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$51.24 - $58.89 $145,111 - $166,776	-2,832 Reduced 6.2%	42,846 $2.28 Million
Q2 2022 Aug 10, 2022	SELL	$51.49 - $81.64 $71,159 - $112,826	-1,382 Reduced 2.94%	45,678 $2.66 Million
Q1 2022 May 17, 2022	BUY	$60.03 - $76.49 $2.83 Million - $3.6 Million	47,060 New	47,060 $3.59 Million

258

49.4M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.17B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.